Portunus trituberculatus isolate SZX2019 chromosome 39, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030109.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC123515555, transcript variant X1
uncharacterized LOC123515555, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123515555, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123515556, transcript variant X2
uncharacterized protein LOC123515556 isoform X2
uncharacterized LOC123515556, transcript variant X3
uncharacterized LOC123515556, transcript variant X1
uncharacterized protein LOC123515556 isoform X3
uncharacterized protein LOC123515556 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
sodium- and chloride-dependent glycine transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium- and chloride-dependent glycine transporter 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123515505, transcript variant X1
uncharacterized LOC123515505, transcript variant X3
uncharacterized LOC123515505, transcript variant X2
putative uncharacterized protein FLJ46204
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC123515415, transcript variant X2
uncharacterized LOC123515415, transcript variant X1
uncharacterized protein LOC123515415 isoform X2
uncharacterized protein LOC123515415 isoform X1
uncharacterized LOC123515416, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123515416, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium- and chloride-dependent glycine transporter 1-like
piggyBac transposable element-derived protein 4-like
mitochondrial proton/calcium exchanger protein-like, transcript variant X1
mitochondrial proton/calcium exchanger protein-like, transcript variant X2
mitochondrial proton/calcium exchanger protein-like isoform X1
mitochondrial proton/calcium exchanger protein-like isoform X2
mitochondrial proton/calcium exchanger protein-like, transcript variant X3
mitochondrial proton/calcium exchanger protein-like isoform X3
eukaryotic translation initiation factor 4 gamma-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC123515447, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123515447, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized protein LOC123515447 isoform X1
uncharacterized protein LOC123515447 isoform X2
F-box only protein 28-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
F-box only protein 28-like, transcript variant X2
F-box only protein 28-like, transcript variant X4
F-box only protein 28-like, transcript variant X3
F-box only protein 28-like, transcript variant X1
RNA-binding protein 39-like, transcript variant X2
RNA-binding protein 39-like, transcript variant X1
pyrimidodiazepine synthase-like, transcript variant X1
pyrimidodiazepine synthase-like, transcript variant X3
pyrimidodiazepine synthase-like, transcript variant X6
pyrimidodiazepine synthase-like, transcript variant X4
pyrimidodiazepine synthase-like, transcript variant X2
pyrimidodiazepine synthase-like, transcript variant X5
pyrimidodiazepine synthase-like isoform X2
pyrimidodiazepine synthase-like isoform X1
pyrimidodiazepine synthase-like isoform X3
uncharacterized LOC123515452, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123515452, transcript variant X2
uncharacterized protein LOC123515452 isoform X1
uncharacterized protein LOC123515452 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
cleavage and polyadenylation specificity factor subunit 5-like
DNA N6-methyl methyltransferase-like, transcript variant X4
DNA N6-methyl methyltransferase-like, transcript variant X5
DNA N6-methyl methyltransferase-like, transcript variant X1
DNA N6-methyl methyltransferase-like, transcript variant X7
DNA N6-methyl methyltransferase-like, transcript variant X3
DNA N6-methyl methyltransferase-like, transcript variant X2
DNA N6-methyl methyltransferase-like, transcript variant X6
DNA N6-methyl methyltransferase-like, transcript variant X8
DNA N6-methyl methyltransferase-like isoform X1
DNA N6-methyl methyltransferase-like isoform X2
NADPH oxidase 4-like, transcript variant X2
NADPH oxidase 4-like, transcript variant X5
NADPH oxidase 4-like, transcript variant X3
NADPH oxidase 4-like, transcript variant X1
NADPH oxidase 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC123515519 isoform X3
uncharacterized LOC123515488, transcript variant X2
uncharacterized LOC123515488, transcript variant X1
uncharacterized protein LOC123515488 isoform X1
uncharacterized protein LOC123515488 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123515490, transcript variant X1
uncharacterized LOC123515490, transcript variant X2
uncharacterized protein LOC123515490 isoform X1
uncharacterized protein LOC123515490 isoform X2
39S ribosomal protein L48, mitochondrial-like
trissin receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
trissin receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
macrophage migration inhibitory factor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
protein PRRC1-like, transcript variant X1
protein PRRC1-like, transcript variant X2
protein PRRC1-like, transcript variant X10
protein PRRC1-like, transcript variant X9
protein PRRC1-like, transcript variant X7
protein PRRC1-like, transcript variant X8
protein PRRC1-like, transcript variant X11
protein PRRC1-like, transcript variant X3
protein PRRC1-like, transcript variant X6
protein PRRC1-like, transcript variant X5
protein PRRC1-like, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
major facilitator superfamily domain-containing protein 3-like, transcript variant X1
major facilitator superfamily domain-containing protein 3-like, transcript variant X2
major facilitator superfamily domain-containing protein 3-like isoform X1
major facilitator superfamily domain-containing protein 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123515630, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123515630, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
la-related protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
la-related protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
la-related protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
la-related protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
telomerase reverse transcriptase-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123515634 isoform X7
von Willebrand factor A domain-containing protein DDB_G0292188-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
telomerase reverse transcriptase-like, transcript variant X9
uncharacterized protein LOC123515634 isoform X6
telomerase reverse transcriptase-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123515634 isoform X5
telomerase reverse transcriptase-like, transcript variant X1
telomerase reverse transcriptase-like, transcript variant X5
telomerase reverse transcriptase-like, transcript variant X3
telomerase reverse transcriptase-like, transcript variant X6
telomerase reverse transcriptase-like, transcript variant X4
telomerase reverse transcriptase-like, transcript variant X2
telomerase reverse transcriptase-like, transcript variant X7
telomerase reverse transcriptase-like isoform X2
telomerase reverse transcriptase-like isoform X1
telomerase reverse transcriptase-like isoform X3
telomerase reverse transcriptase-like isoform X4
telomerase reverse transcriptase-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
RNA cytidine acetyltransferase-like, transcript variant X4
RNA cytidine acetyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA cytidine acetyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RNA cytidine acetyltransferase-like, transcript variant X2
RNA cytidine acetyltransferase-like isoform X2
RNA cytidine acetyltransferase-like isoform X4
RNA cytidine acetyltransferase-like isoform X3
RNA cytidine acetyltransferase-like isoform X1
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X2
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X1
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like isoform X1
oplophorus-luciferin 2-monooxygenase non-catalytic subunit-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 60% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
similar to RNA sequence (same species):INSD:GFFJ01033633.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 1097 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 1097 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 64% coverage of the annotated genomic feature by RNAseq alignments
nitric oxide-associated protein 1-like, transcript variant X1
nitric oxide-associated protein 1-like, transcript variant X3
nitric oxide-associated protein 1-like isoform X1
nitric oxide-associated protein 1-like isoform X3
nitric oxide-associated protein 1-like, transcript variant X2
nitric oxide-associated protein 1-like isoform X2
uncharacterized LOC123515655, transcript variant X7
uncharacterized LOC123515655, transcript variant X2
uncharacterized LOC123515655, transcript variant X10
uncharacterized LOC123515655, transcript variant X13
uncharacterized LOC123515655, transcript variant X8
uncharacterized LOC123515655, transcript variant X1
uncharacterized LOC123515655, transcript variant X11
uncharacterized LOC123515655, transcript variant X14
uncharacterized LOC123515655, transcript variant X12
uncharacterized LOC123515655, transcript variant X15
uncharacterized LOC123515655, transcript variant X5
uncharacterized LOC123515655, transcript variant X6
uncharacterized LOC123515655, transcript variant X4
uncharacterized LOC123515655, transcript variant X9
uncharacterized LOC123515655, transcript variant X3
uncharacterized LOC123515654, transcript variant X1
uncharacterized LOC123515654, transcript variant X3
uncharacterized LOC123515654, transcript variant X2
uncharacterized LOC123515654, transcript variant X4
uncharacterized LOC123515654, transcript variant X5
uncharacterized LOC123515654, transcript variant X6
PH domain-containing protein DDB_G0287875-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
PH domain-containing protein DDB_G0287875-like, transcript variant X2
uncharacterized protein LOC123515651 isoform X2
PH domain-containing protein DDB_G0287875-like isoform X1
RING finger and CHY zinc finger domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RING finger and CHY zinc finger domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RING finger and CHY zinc finger domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RING finger and CHY zinc finger domain-containing protein 1-like isoform X1
RING finger and CHY zinc finger domain-containing protein 1-like isoform X2
RING finger and CHY zinc finger domain-containing protein 1-like isoform X3
uncharacterized LOC123515662, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123515662, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123515662, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123515662, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123515662, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123515662, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123515662, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tigger transposable element-derived protein 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
putative nuclease HARBI1, transcript variant X2
putative nuclease HARBI1, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123515665
uncharacterized LOC123515667, transcript variant X3
uncharacterized LOC123515667, transcript variant X1
uncharacterized LOC123515667, transcript variant X2
glyoxylate/hydroxypyruvate reductase A-like, transcript variant X1
glyoxylate/hydroxypyruvate reductase A-like isoform X1
glyoxylate/hydroxypyruvate reductase A-like, transcript variant X2
glyoxylate/hydroxypyruvate reductase A-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
ionotropic receptor 25a-like, transcript variant X1
ionotropic receptor 25a-like, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: ionotropic receptor 93a-like
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
KAT8 regulatory NSL complex subunit 2-like, transcript variant X1
KAT8 regulatory NSL complex subunit 2-like, transcript variant X4
KAT8 regulatory NSL complex subunit 2-like, transcript variant X2
KAT8 regulatory NSL complex subunit 2-like, transcript variant X3
KAT8 regulatory NSL complex subunit 2-like
actin-related protein 2-B-like, transcript variant X1
actin-related protein 2-B-like, transcript variant X3
actin-related protein 2-B-like, transcript variant X2
actin-related protein 2-B-like, transcript variant X4
actin-related protein 2-B-like isoform X1
actin-related protein 2-B-like isoform X3
actin-related protein 2-B-like isoform X2
actin-related protein 2-B-like isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: protein tramtrack, beta isoform-like
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein DDB_G0290301-like, transcript variant X1
uncharacterized protein DDB_G0290301-like, transcript variant X2
uncharacterized protein DDB_G0290301-like isoform X2
putative uncharacterized protein DDB_G0291608 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
UDP-glycosyltransferase UGT5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-glycosyltransferase UGT5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glycosyltransferase UGT5-like isoform X1
UDP-glycosyltransferase UGT5-like isoform X2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LOW QUALITY PROTEIN: ras-related protein Rap-2a-like
zinc finger BED domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
thrombospondin type-1 domain-containing protein 7B-like, transcript variant X1
thrombospondin type-1 domain-containing protein 7B-like, transcript variant X2
thrombospondin type-1 domain-containing protein 7B-like isoform X1
thrombospondin type-1 domain-containing protein 7B-like isoform X2
putative neural-cadherin 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative neural-cadherin 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative neural-cadherin 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative neural-cadherin 2, transcript variant X3
putative neural-cadherin 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
xylosyltransferase oxt-like, transcript variant X1
xylosyltransferase oxt-like, transcript variant X2
xylosyltransferase oxt-like, transcript variant X3
probable G-protein coupled receptor AH9.1, transcript variant X5
probable G-protein coupled receptor AH9.1, transcript variant X1
probable G-protein coupled receptor AH9.1, transcript variant X2
probable G-protein coupled receptor AH9.1, transcript variant X3
probable G-protein coupled receptor AH9.1, transcript variant X4
probable G-protein coupled receptor AH9.1 isoform X1
probable G-protein coupled receptor AH9.1 isoform X2
cytochrome c oxidase assembly protein COX15 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
LOW QUALITY PROTEIN: protein fantom-like
cell cycle checkpoint protein RAD17-like, transcript variant X2
cell cycle checkpoint protein RAD17-like, transcript variant X4
cell cycle checkpoint protein RAD17-like, transcript variant X3
cell cycle checkpoint protein RAD17-like, transcript variant X1
cell cycle checkpoint protein RAD17-like, transcript variant X5
cell cycle checkpoint protein RAD17-like, transcript variant X6
cell cycle checkpoint protein RAD17-like, transcript variant X7
cell cycle checkpoint protein RAD17-like isoform X1
cell cycle checkpoint protein RAD17-like isoform X2
COMM domain-containing protein 4-like, transcript variant X2
COMM domain-containing protein 4-like, transcript variant X4
COMM domain-containing protein 4-like, transcript variant X1
COMM domain-containing protein 4-like, transcript variant X3
COMM domain-containing protein 4-like isoform X1
COMM domain-containing protein 4-like isoform X2
ras-related protein Rac1, transcript variant X2
ras-related protein Rac1, transcript variant X1
ras-related protein Rac1, transcript variant X3
uncharacterized LOC123515600, transcript variant X1
uncharacterized LOC123515600, transcript variant X5
uncharacterized LOC123515600, transcript variant X6
uncharacterized LOC123515600, transcript variant X3
uncharacterized LOC123515600, transcript variant X2
uncharacterized LOC123515600, transcript variant X4
uncharacterized protein LOC123515600 isoform X1
uncharacterized protein LOC123515600 isoform X5
uncharacterized protein LOC123515600 isoform X6
uncharacterized protein LOC123515600 isoform X3
uncharacterized protein LOC123515600 isoform X2
uncharacterized protein LOC123515600 isoform X4
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LOW QUALITY PROTEIN: endoplasmic reticulum lectin 1-like
LOW QUALITY PROTEIN: TATA-box-binding protein-like
LOW QUALITY PROTEIN: uncharacterized protein LOC123515481
39S ribosomal protein L13, mitochondrial-like
protein Pixie-like, transcript variant X1
protein Pixie-like, transcript variant X2
zinc finger protein 84-like, transcript variant X2
zinc finger protein 84-like, transcript variant X1
39S ribosomal protein L43, mitochondrial-like
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2-like, transcript variant X1
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2-like, transcript variant X4
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2-like, transcript variant X2
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2-like, transcript variant X3
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2-like
methionine aminopeptidase 1D, mitochondrial-like
proline-rich receptor-like protein kinase PERK9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: TBC1 domain family member 16-like
serine protease persephone-like, transcript variant X1
serine protease persephone-like, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X4
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X5
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X3
LOW QUALITY PROTEIN: bifunctional coenzyme A synthase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat extensin-like protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 1B-like
snurportin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
snurportin-1-like, transcript variant X1
snurportin-1-like, transcript variant X5
snurportin-1-like, transcript variant X4
snurportin-1-like, transcript variant X3
intraflagellar transport protein 81 homolog, transcript variant X1
intraflagellar transport protein 81 homolog, transcript variant X2
intraflagellar transport protein 81 homolog
uncharacterized LOC123515770, transcript variant X2
uncharacterized LOC123515770, transcript variant X1
uncharacterized LOC123515769, transcript variant X1
uncharacterized LOC123515769, transcript variant X2
uncharacterized LOC123515768, transcript variant X2
uncharacterized LOC123515768, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 36% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: mutS protein homolog 4-like
tetraspanin-9-like, transcript variant X2
tetraspanin-9-like, transcript variant X4
tetraspanin-9-like, transcript variant X1
tetraspanin-9-like, transcript variant X3
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: furin-like protease 1, isoforms 1/1-X/2
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X1
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X2
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X4
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X3
fatty acid hydroxylase domain-containing protein 2-like
target of rapamycin complex subunit lst8-like
phospholipid phosphatase 6-like, transcript variant X1
phospholipid phosphatase 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123515697, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123515697, transcript variant X3
uncharacterized LOC123515697, transcript variant X1
uncharacterized LOC123515613, transcript variant X7
uncharacterized LOC123515613, transcript variant X6
uncharacterized protein LOC123515613 isoform X3
uncharacterized LOC123515613, transcript variant X4
uncharacterized LOC123515613, transcript variant X1
uncharacterized LOC123515613, transcript variant X5
uncharacterized LOC123515613, transcript variant X3
uncharacterized LOC123515613, transcript variant X2
uncharacterized protein LOC123515613 isoform X2
uncharacterized protein LOC123515613 isoform X1
dynein regulatory complex protein 9-like
putative neural-cadherin 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L
ATP-citrate synthase-like, transcript variant X4
ATP-citrate synthase-like, transcript variant X1
ATP-citrate synthase-like, transcript variant X5
ATP-citrate synthase-like, transcript variant X2
ATP-citrate synthase-like, transcript variant X3
thyroid receptor-interacting protein 6-like, transcript variant X5
thyroid receptor-interacting protein 6-like, transcript variant X1
thyroid receptor-interacting protein 6-like, transcript variant X3
thyroid receptor-interacting protein 6-like, transcript variant X2
thyroid receptor-interacting protein 6-like, transcript variant X4
thyroid receptor-interacting protein 6-like isoform X2
thyroid receptor-interacting protein 6-like isoform X1
thyroid receptor-interacting protein 6-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
lipoma-preferred partner homolog isoform X3
vang-like protein 1, transcript variant X2
vang-like protein 1, transcript variant X1
acyl-CoA:lysophosphatidylglycerol acyltransferase 1-like
uncharacterized LOC123515567, transcript variant X1
uncharacterized LOC123515567, transcript variant X3
uncharacterized LOC123515567, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
gem-associated protein 8-like, transcript variant X1
gem-associated protein 8-like, transcript variant X2
gem-associated protein 8-like isoform X1
gem-associated protein 8-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
homeobox protein prospero-like, transcript variant X8
homeobox protein prospero-like, transcript variant X7
homeobox protein prospero-like, transcript variant X6
homeobox protein prospero-like, transcript variant X5
homeobox protein prospero-like, transcript variant X4
homeobox protein prospero-like, transcript variant X3
homeobox protein prospero-like, transcript variant X2
homeobox protein prospero-like, transcript variant X1
homeobox protein prospero-like, transcript variant X9
homeobox protein prospero-like isoform X8
homeobox protein prospero-like isoform X7
homeobox protein prospero-like isoform X6
homeobox protein prospero-like isoform X5
homeobox protein prospero-like isoform X4
homeobox protein prospero-like isoform X3
homeobox protein prospero-like isoform X2
homeobox protein prospero-like isoform X1
homeobox protein prospero-like isoform X9
homeobox protein prospero-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
homeobox protein prospero-like, transcript variant X11
homeobox protein prospero-like isoform X10
homeobox protein prospero-like isoform X11
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123515704, transcript variant X5
uncharacterized LOC123515704, transcript variant X8
uncharacterized LOC123515704, transcript variant X4
uncharacterized LOC123515704, transcript variant X7
uncharacterized LOC123515704, transcript variant X9
uncharacterized LOC123515704, transcript variant X6
uncharacterized LOC123515704, transcript variant X10
uncharacterized LOC123515704, transcript variant X2
uncharacterized LOC123515704, transcript variant X1
uncharacterized LOC123515704, transcript variant X3
uncharacterized protein LOC123515704 isoform X2
uncharacterized protein LOC123515704 isoform X1
uncharacterized protein LOC123515704 isoform X3
uncharacterized LOC123515596, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123515596, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123515596, transcript variant X2
uncharacterized LOC123515596, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC123515596 isoform X1
uncharacterized LOC123515596, transcript variant X5
uncharacterized protein LOC123515596 isoform X2
uncharacterized LOC123515597, transcript variant X1
uncharacterized LOC123515597, transcript variant X2
uncharacterized LOC123515572, transcript variant X1
uncharacterized LOC123515572, transcript variant X2
uncharacterized LOC123515572, transcript variant X3
SHC SH2 domain-binding protein 1 homolog B-like, transcript variant X1
SHC SH2 domain-binding protein 1 homolog B-like isoform X1
SHC SH2 domain-binding protein 1 homolog B-like, transcript variant X3
SHC SH2 domain-binding protein 1 homolog B-like, transcript variant X2
SHC SH2 domain-binding protein 1 homolog B-like isoform X2
ankyrin repeat family A protein 2-like, transcript variant X4
ankyrin repeat family A protein 2-like, transcript variant X2
ankyrin repeat family A protein 2-like, transcript variant X1
ankyrin repeat family A protein 2-like isoform X1
ankyrin repeat family A protein 2-like, transcript variant X3
ankyrin repeat family A protein 2-like, transcript variant X5
ankyrin repeat family A protein 2-like isoform X2
LOW QUALITY PROTEIN: follistatin-related protein 5-like
D-2-hydroxyglutarate dehydrogenase, mitochondrial-like, transcript variant X4
D-2-hydroxyglutarate dehydrogenase, mitochondrial-like, transcript variant X1
D-2-hydroxyglutarate dehydrogenase, mitochondrial-like, transcript variant X3
D-2-hydroxyglutarate dehydrogenase, mitochondrial-like isoform X1
D-2-hydroxyglutarate dehydrogenase, mitochondrial-like, transcript variant X2
D-2-hydroxyglutarate dehydrogenase, mitochondrial-like isoform X2
mpv17-like protein, transcript variant X4
mpv17-like protein, transcript variant X2
mpv17-like protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mpv17-like protein, transcript variant X1
mpv17-like protein, transcript variant X7
mpv17-like protein, transcript variant X5
mpv17-like protein, transcript variant X3
synaptogyrin-like, transcript variant X4
synaptogyrin-like, transcript variant X1
synaptogyrin-like, transcript variant X3
synaptogyrin-like, transcript variant X2
FACT complex subunit Ssrp1-like, transcript variant X1
FACT complex subunit Ssrp1-like, transcript variant X2
FACT complex subunit Ssrp1-like isoform X1
FACT complex subunit Ssrp1-like isoform X2
uncharacterized LOC123515409, transcript variant X2
uncharacterized LOC123515409, transcript variant X1
LOW QUALITY PROTEIN: uncharacterized protein LOC123515402
eukaryotic translation initiation factor 2D-like, transcript variant X2
eukaryotic translation initiation factor 2D-like, transcript variant X1
eukaryotic translation initiation factor 2D-like isoform X2
eukaryotic translation initiation factor 2D-like isoform X1
tetratricopeptide repeat protein 9C-like, transcript variant X1
tetratricopeptide repeat protein 9C-like, transcript variant X2
tetratricopeptide repeat protein 9C-like isoform X1
tetratricopeptide repeat protein 9C-like isoform X2
two pore calcium channel protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
two pore calcium channel protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
two pore calcium channel protein 1-like isoform X2
two pore calcium channel protein 1-like isoform X1
trafficking protein particle complex subunit 8-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: trafficking protein particle complex subunit 8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like
uncharacterized LOC123515414, transcript variant X1
uncharacterized LOC123515414, transcript variant X2
LOW QUALITY PROTEIN: uncharacterized protein LOC123515439
Golgi SNAP receptor complex member 2-like
farnesyl pyrophosphate synthase-like, transcript variant X2
farnesyl pyrophosphate synthase-like, transcript variant X5
farnesyl pyrophosphate synthase-like, transcript variant X1
farnesyl pyrophosphate synthase-like, transcript variant X3
farnesyl pyrophosphate synthase-like, transcript variant X4
farnesyl pyrophosphate synthase-like isoform X1
farnesyl pyrophosphate synthase-like isoform X2
uncharacterized LOC123515366, transcript variant X1
uncharacterized LOC123515366, transcript variant X2
uncharacterized protein LOC123515366 isoform X1
uncharacterized protein LOC123515366 isoform X2
LOW QUALITY PROTEIN: E3 SUMO-protein ligase PIAS2-like
uncharacterized LOC123515373, transcript variant X4
uncharacterized LOC123515373, transcript variant X3
uncharacterized LOC123515373, transcript variant X5
uncharacterized LOC123515373, transcript variant X1
uncharacterized LOC123515373, transcript variant X2
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X4
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X20
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X10
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X19
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X14
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X26
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X46
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X42
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X48
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X38
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X35
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X37
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X33
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X11
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X44
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X47
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X43
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X40
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X45
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X36
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X31
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X34
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X30
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X41
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X39
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X13
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X15
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X9
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X28
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X32
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X29
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X27
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X25
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X23
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X12
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X24
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X8
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X6
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X17
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X18
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X22
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X21
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X3
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X16
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X7
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X5
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X49
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X50
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X5
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X20
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X10
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X19
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X14
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X26
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X46
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X42
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X48
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X38
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X35
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X37
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X33
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X11
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X44
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X47
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X43
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X40
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X45
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X36
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X31
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X34
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X30
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X41
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X39
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X13
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X15
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X9
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X28
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X32
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X29
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X27
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X25
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X23
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X12
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X24
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X8
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X6
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X17
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X18
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X22
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X21
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X3
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X16
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X7
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X2
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X1
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X50
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X49
protein HGH1 homolog, transcript variant X3
protein HGH1 homolog, transcript variant X2
protein HGH1 homolog, transcript variant X1
protein HGH1 homolog, transcript variant X4
histone acetyltransferase Tip60-like, transcript variant X2
histone acetyltransferase Tip60-like, transcript variant X1
histone acetyltransferase Tip60-like isoform X2
histone acetyltransferase KAT5-like isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X2
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like
sec1 family domain-containing protein 1-like
selenocysteine-specific elongation factor-like
LOW QUALITY PROTEIN: selenocysteine-specific elongation factor-like
UPF0488 protein CG14286-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
UPF0488 protein CG14286-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized protein LOC123515424 isoform X2
CCR4-NOT transcription complex subunit 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 6-like, transcript variant X1
CCR4-NOT transcription complex subunit 6-like, transcript variant X2
CCR4-NOT transcription complex subunit 6-like isoform X3
CCR4-NOT transcription complex subunit 6-like isoform X1
CCR4-NOT transcription complex subunit 6-like isoform X2
uncharacterized LOC123515508, transcript variant X2
uncharacterized LOC123515508, transcript variant X1
uncharacterized LOC123515508, transcript variant X4
uncharacterized LOC123515508, transcript variant X3
uncharacterized protein LOC123515508 isoform X1
uncharacterized protein LOC123515508 isoform X2
uncharacterized protein LOC123515508 isoform X3
uncharacterized protein LOC123515508 isoform X4
glutamate receptor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate receptor 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC123515509 isoform X2
uncharacterized LOC123515511, transcript variant X3
uncharacterized LOC123515511, transcript variant X2
uncharacterized LOC123515511, transcript variant X5
uncharacterized LOC123515511, transcript variant X6
uncharacterized LOC123515511, transcript variant X8
uncharacterized LOC123515511, transcript variant X1
uncharacterized LOC123515511, transcript variant X7
uncharacterized LOC123515511, transcript variant X4
E3 ubiquitin-protein ligase TRIM17-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM17-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM17-like, transcript variant X4
E3 ubiquitin-protein ligase TRIM17-like, transcript variant X3
E3 ubiquitin-protein ligase TRIM17-like, transcript variant X5
tripartite motif-containing 13-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tripartite motif-containing 13-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 long SRA reads, 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123515695, transcript variant X1
uncharacterized LOC123515695, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123515595, transcript variant X2
uncharacterized LOC123515595, transcript variant X1
uncharacterized protein LOC123515595 isoform X1
uncharacterized protein LOC123515595 isoform X2
6-pyruvoyl tetrahydrobiopterin synthase-like
LOW QUALITY PROTEIN: nuclear receptor coactivator 6-like
LOW QUALITY PROTEIN: protein germ cell-less-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
dentin sialophosphoprotein-like isoform X1
guanine nucleotide exchange factor MSS4 homolog, transcript variant X1
guanine nucleotide exchange factor MSS4 homolog, transcript variant X2
guanine nucleotide exchange factor MSS4 homolog isoform X1
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like
LOW QUALITY PROTEIN: U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like
guanine nucleotide exchange factor MSS4 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123515705, transcript variant X2
uncharacterized LOC123515705, transcript variant X1
uncharacterized protein LOC123515705 isoform X1
uncharacterized protein LOC123515705 isoform X2
N-acetylgalactosaminyltransferase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein C12orf56-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium-activated chloride channel regulator 2-like isoform X1
BRO1 domain-containing protein BROX-like
open rectifier potassium channel protein 1-like, transcript variant X1
open rectifier potassium channel protein 1-like, transcript variant X2
open rectifier potassium channel protein 1-like, transcript variant X3
potassium channel subfamily K member 4-like isoform X1
open rectifier potassium channel protein 1-like isoform X2
open rectifier potassium channel protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
uncharacterized LOC123515438, transcript variant X1
uncharacterized LOC123515438, transcript variant X2
uncharacterized LOC123515438, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: putative neural-cadherin 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase PAK 2-like, transcript variant X1
serine/threonine-protein kinase PAK 2-like, transcript variant X2
serine/threonine-protein kinase PAK 2-like, transcript variant X3
serine/threonine-protein kinase PAK 2-like isoform X1
serine/threonine-protein kinase PAK 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123515359
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123515357
glutamate receptor ionotropic, delta-2-like
dehydrogenase/reductase SDR family member 11-like, transcript variant X1
dehydrogenase/reductase SDR family member 11-like, transcript variant X2
dehydrogenase/reductase SDR family member 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
GATA zinc finger domain-containing protein 14-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GATA zinc finger domain-containing protein 14-like, transcript variant X2
GATA zinc finger domain-containing protein 14-like isoform X1
uncharacterized protein LOC123515474 isoform X2
THUMP domain-containing protein 3-like, transcript variant X1
THUMP domain-containing protein 3-like, transcript variant X3
THUMP domain-containing protein 3-like, transcript variant X2
calcium-activated chloride channel regulator family member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 88% coverage of the annotated genomic feature by RNAseq alignments
calcium-activated chloride channel regulator 2-like
uncharacterized LOC123515730, transcript variant X3
uncharacterized LOC123515730, transcript variant X2
uncharacterized LOC123515730, transcript variant X1
uncharacterized LOC123515604, transcript variant X5
uncharacterized LOC123515604, transcript variant X2
uncharacterized LOC123515604, transcript variant X3
uncharacterized LOC123515604, transcript variant X7
uncharacterized LOC123515604, transcript variant X6
uncharacterized LOC123515604, transcript variant X1
uncharacterized LOC123515604, transcript variant X4
LOW QUALITY PROTEIN: uncharacterized protein LOC123515606
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123515611
store-operated calcium entry regulator STIMATE-like
ATP-dependent RNA helicase SUV3 homolog, mitochondrial-like
RING finger protein 44-like, transcript variant X6
RING finger protein 44-like, transcript variant X1
RING finger protein 44-like, transcript variant X2
RING finger protein 44-like, transcript variant X8
RING finger protein 44-like, transcript variant X4
RING finger protein 44-like, transcript variant X3
RING finger protein 44-like, transcript variant X5
RING finger protein 44-like, transcript variant X7
RING finger protein 44-like, transcript variant X9
pseudouridine-metabolizing bifunctional protein C1861.05-like, transcript variant X1
pseudouridine-metabolizing bifunctional protein C1861.05-like, transcript variant X2
pseudouridine-metabolizing bifunctional protein C1861.05-like isoform X1
pseudouridine-metabolizing bifunctional protein C1861.05-like isoform X2
leukocyte antigen CD37-like, transcript variant X3
leukocyte antigen CD37-like, transcript variant X2
leukocyte antigen CD37-like, transcript variant X1
uncharacterized LOC123515588, transcript variant X8
uncharacterized LOC123515588, transcript variant X1
uncharacterized LOC123515588, transcript variant X7
uncharacterized LOC123515588, transcript variant X2
uncharacterized LOC123515588, transcript variant X4
uncharacterized LOC123515588, transcript variant X6
uncharacterized LOC123515588, transcript variant X3
uncharacterized LOC123515588, transcript variant X5
uncharacterized protein LOC123515588 isoform X2
uncharacterized protein LOC123515588 isoform X1
uncharacterized LOC123515590, transcript variant X2
uncharacterized LOC123515590, transcript variant X1
uncharacterized protein LOC123515590 isoform X2
uncharacterized protein LOC123515590 isoform X1
presenilins-associated rhomboid-like protein, mitochondrial
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X2
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X3
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X4
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X5
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X8
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X7
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X6
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X11
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X9
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like, transcript variant X10
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X7
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X1
serine/threonine-protein phosphatase 6 regulatory subunit 3-A-like isoform X4
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X2
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X6
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X8
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X9
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X5
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X10
serine/threonine-protein phosphatase 6 regulatory subunit 3-like isoform X3
vam6/Vps39-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
vam6/Vps39-like protein, transcript variant X1
vam6/Vps39-like protein, transcript variant X3
insulin-like growth factor-binding protein complex acid labile subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
putative inositol monophosphatase 3, transcript variant X3
putative inositol monophosphatase 3, transcript variant X5
putative inositol monophosphatase 3, transcript variant X2
putative inositol monophosphatase 3, transcript variant X4
putative inositol monophosphatase 3, transcript variant X1
inositol monophosphatase 3-like isoform X2
inositol monophosphatase 3-like isoform X1
putative inositol monophosphatase 3 isoform X3
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like, transcript variant X1
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like, transcript variant X2
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like isoform X1
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like isoform X2
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 15-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: selenoprotein F-like
alpha-2-macroglobulin receptor-associated protein-like
saccharopine dehydrogenase-like oxidoreductase
pre-rRNA-processing protein TSR1 homolog, transcript variant X1
pre-rRNA-processing protein TSR1 homolog, transcript variant X2
pre-rRNA-processing protein TSR1 homolog isoform X1
pre-rRNA-processing protein TSR1 homolog isoform X2
60S ribosomal protein L7-like, transcript variant X1
60S ribosomal protein L7-like isoform X1
60S ribosomal protein L7-like, transcript variant X3
60S ribosomal protein L7-like isoform X3
60S ribosomal protein L7-like, transcript variant X2
60S ribosomal protein L7-like isoform X2
adenylate cyclase CyaB-like, transcript variant X5
adenylate cyclase CyaB-like, transcript variant X2
adenylate cyclase CyaB-like, transcript variant X4
adenylate cyclase CyaB-like, transcript variant X1
adenylate cyclase CyaB-like, transcript variant X3
ATP synthase subunit alpha, mitochondrial-like
LOW QUALITY PROTEIN: ATP synthase subunit alpha, mitochondrial-like
twisted gastrulation protein homolog 1-B-like, transcript variant X2
twisted gastrulation protein homolog 1-B-like, transcript variant X1
twisted gastrulation protein homolog 1-B-like isoform X1
twisted gastrulation protein homolog 1-B-like isoform X2
sugar transporter ERD6-like 4, transcript variant X5
sugar transporter ERD6-like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dehydrogenase/reductase SDR family member 11-like isoform X1
dehydrogenase/reductase SDR family member 11-like isoform X2
dehydrogenase/reductase SDR family member 11-like, transcript variant X3
dehydrogenase/reductase SDR family member 11-like isoform X3
sugar transporter ERD6-like 4, transcript variant X2
sugar transporter ERD6-like 4 isoform X1
facilitated trehalose transporter Tret1-like isoform X4
sugar transporter ERD6-like 4, transcript variant X3
sugar transporter ERD6-like 4 isoform X2
sugar transporter ERD6-like 4, transcript variant X4
sugar transporter ERD6-like 4 isoform X3
uncharacterized LOC123515379, transcript variant X8
uncharacterized LOC123515379, transcript variant X2
uncharacterized LOC123515379, transcript variant X5
uncharacterized LOC123515379, transcript variant X3
uncharacterized LOC123515379, transcript variant X6
uncharacterized LOC123515379, transcript variant X7
uncharacterized LOC123515379, transcript variant X1
uncharacterized LOC123515379, transcript variant X4
uncharacterized LOC123515379, transcript variant X9
ethanolamine kinase 1-like, transcript variant X3
ethanolamine kinase 1-like, transcript variant X2
ethanolamine kinase 1-like, transcript variant X1
ethanolamine kinase 1-like, transcript variant X4
ethanolamine kinase 1-like, transcript variant X6
ethanolamine kinase 1-like, transcript variant X5
ethanolamine kinase 1-like, transcript variant X7
protein brambleberry-like, transcript variant X2
protein brambleberry-like, transcript variant X1
39S ribosomal protein L55, mitochondrial-like
LOW QUALITY PROTEIN: RNA-binding protein spenito-like
WD repeat-containing protein 44-like, transcript variant X6
WD repeat-containing protein 44-like, transcript variant X2
WD repeat-containing protein 44-like, transcript variant X11
WD repeat-containing protein 44-like, transcript variant X10
WD repeat-containing protein 44-like, transcript variant X9
WD repeat-containing protein 44-like, transcript variant X8
WD repeat-containing protein 44-like, transcript variant X7
WD repeat-containing protein 44-like, transcript variant X3
WD repeat-containing protein 44-like, transcript variant X5
WD repeat-containing protein 44-like, transcript variant X4
WD repeat-containing protein 44-like, transcript variant X1
WD repeat-containing protein 44-like isoform X6
WD repeat-containing protein 44-like isoform X2
WD repeat-containing protein 44-like isoform X11
WD repeat-containing protein 44-like isoform X10
WD repeat-containing protein 44-like isoform X9
WD repeat-containing protein 44-like isoform X8
WD repeat-containing protein 44-like isoform X7
WD repeat-containing protein 44-like isoform X3
WD repeat-containing protein 44-like isoform X5
WD repeat-containing protein 44-like isoform X4
WD repeat-containing protein 44-like isoform X1
potassium channel subfamily K member 18-like, transcript variant X1
potassium channel subfamily K member 18-like, transcript variant X3
potassium channel subfamily K member 18-like, transcript variant X2
potassium channel subfamily K member 18-like
RNA polymerase II-associated factor 1 homolog, transcript variant X1
RNA polymerase II-associated factor 1 homolog, transcript variant X2
RNA polymerase II-associated factor 1 homolog isoform X2
RNA polymerase II-associated factor 1 homolog isoform X1
mitogen-activated protein kinase kinase kinase 13-like
ribosomal oxygenase 1-like, transcript variant X1
ribosomal oxygenase 1-like, transcript variant X2
rho-related GTP-binding protein RhoU-like
uncharacterized LOC123515680, transcript variant X3
uncharacterized LOC123515680, transcript variant X4
uncharacterized LOC123515680, transcript variant X2
uncharacterized LOC123515680, transcript variant X1
transcription factor HES-1-A-like, transcript variant X1
transcription factor HES-1-A-like, transcript variant X2
splicing factor U2AF 35 kDa subunit-like, transcript variant X1
splicing factor U2AF 35 kDa subunit-like isoform X1
splicing factor U2AF 35 kDa subunit-like, transcript variant X2
splicing factor U2AF 35 kDa subunit-like isoform X2
adipocyte plasma membrane-associated protein-like
uncharacterized LOC123515553, transcript variant X1
uncharacterized LOC123515553, transcript variant X2
ZZ-type zinc finger-containing protein 3-like
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123515483, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC123515483, transcript variant X3
uncharacterized LOC123515483, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns